Carson Advisory’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Carson Advisory’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,550	Closed	-$35.9K	–	181
2024 Q1	$35.9K	Hold	22,550	–	–	0.03%	173
2023 Q4	$19.4K	Buy	22,550 +6,700	+42%	+$5.88K	0.02%	159
2023 Q3	$17K	Buy	+15,850	New	+$32.8K	0.01%	149

Carson Advisory's NGM Position: Q2 2024 in Review

Carson Advisory sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 22,550 shares — an estimated $35.9K sold.

Carson Advisory first reported a position in NGM in Q3 2023 and held it in 3 quarters. The position peaked at $35.9K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Carson Advisory reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Carson Advisory sold 22,550 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $35.9K.
Carson Advisory first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Carson Advisory's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $35.9K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Carson Advisory's 13F filing for Q2 2024, filed 7 Aug 2024.